Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Cole

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Chemical Science|November 18, 2017
A new route to N-aromatic heterocycles from the hydrogenation of diesters in the presence of anilinesYiping Shi, Paul C J Kamer, David J Cole-Hamilton, et al.
Oncoimmunology|July 29, 2016
Harnessing the IL-7/IL-7Rα axis to improve tumor immunotherapyC Bryce Johnson, John Wrangle, Shikhar Mehrotra, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cellsMohamed L Salem, Andre N Kadima, Sabry A El-Naggar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 15, 2015
Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumorsJie Wang, Ze Lu, Junfeng Wang, et al.
Dalton Transactions (Cambridge, England : 2003)|November 29, 2005
Rhodium catalysed hydroformylation of alkenes using highly fluorophilic phosphinesDave J Adams, James A Bennett, David J Cole-Hamilton, et al.
Brachytherapy|September 10, 2008
Incidence and prognostic factors for seroma development after MammoSite breast brachytherapyJohn M Watkins, Jennifer L Harper, Anthony E Dragun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancerKaidi Mikhitarian, William E Gillanders, Jonas S Almeida, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2007
Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine modelC Marcela Díaz-Montero, Sabry El Naggar, Amir Al Khami, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 19, 2006
Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activityMohamed Labib Salem, William E Gillanders, Andre N Kadima, et al.
Breast Cancer Research and Treatment|August 16, 2023
The impact of nurse navigation on timeliness to treatment for benign high-risk breast pathologyCatherine S Barker, Catherine W Chung, Rupak Mukherjee, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Chemical Science|November 18, 2017
A new route to N-aromatic heterocycles from the hydrogenation of diesters in the presence of anilinesYiping Shi, Paul C J Kamer, David J Cole-Hamilton, et al.
Oncoimmunology|July 29, 2016
Harnessing the IL-7/IL-7Rα axis to improve tumor immunotherapyC Bryce Johnson, John Wrangle, Shikhar Mehrotra, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cellsMohamed L Salem, Andre N Kadima, Sabry A El-Naggar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 15, 2015
Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumorsJie Wang, Ze Lu, Junfeng Wang, et al.
Dalton Transactions (Cambridge, England : 2003)|November 29, 2005
Rhodium catalysed hydroformylation of alkenes using highly fluorophilic phosphinesDave J Adams, James A Bennett, David J Cole-Hamilton, et al.
Brachytherapy|September 10, 2008
Incidence and prognostic factors for seroma development after MammoSite breast brachytherapyJohn M Watkins, Jennifer L Harper, Anthony E Dragun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancerKaidi Mikhitarian, William E Gillanders, Jonas S Almeida, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2007
Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine modelC Marcela Díaz-Montero, Sabry El Naggar, Amir Al Khami, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 19, 2006
Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activityMohamed Labib Salem, William E Gillanders, Andre N Kadima, et al.
Breast Cancer Research and Treatment|August 16, 2023
The impact of nurse navigation on timeliness to treatment for benign high-risk breast pathologyCatherine S Barker, Catherine W Chung, Rupak Mukherjee, et al.
Pageof 14